Influence of inhaled corticosteroids on community-acquired pneumonia in patients with bronchial asthma

Internal Medicine

Volumn 43, Issue 8, 2004, Pages 674-678

  To, Masako ^a   To, Yasao ^a   Yamada, Hirokazu ^a   Ogawa, Chuhei ^a   Otomo, Mamoru ^a   Suzuki, Naohito ^a   Sano, Yasuyuki ^a  

^a Doai Memorial Hospital   (Japan)

Author keywords

Bronchial asthma; Community acquired pneumonia; Inhaled corticosteroid; Microorganism; Resolution period of pneumonia

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; BODY TEMPERATURE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE CONTROL; DISEASE DURATION; FEMALE; FREQUENCY ANALYSIS; GROUPS BY AGE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PATHOGENESIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; AGED; ASTHMA; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; TREATMENT OUTCOME;

EID: 4644270586     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.674     Document Type: Article

References (14)

1. Watanabe Y, Tanaka H, Ogawa T. Influence of beclomethason dipropionate inhalation therapy on respiratory bacterial infection in patients with an asthmatic attack. Arerugi (Jpn J Allergol) 46: 1132-1135, 1997 (in Japanese, Abstract in English).
2. Toogood JH. Complications of topical steroid therapy for asthma. Am Rev Respir Dis 141: S89-S96, 1990.
3. Second report of the Brompton Hospital/Medical Research Council Collaborative Trial. Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol with a placebo in chronic bronchial asthma. Br J Dis Chest 73: 121-132, 1979.
4. Tarlo S, Broder I, Spence LA. Prospective study of respiratory infection in adult asthmatics and their normal spouses. Clin Allergy 9: 293-301, 1979.
5. Okimoto N, Sunagawa N, Asaoka N, et al. Influence of steroid inhalation therapy on microorganism of respiratory infections in patients with bronchial asthma. Kansenshogaku Zasshi 73: 1165-1166, 1999 (in Japanese, Abstract in English).
6. Global Initiative for asthma. Global strategy for asthma management and prevention NHLBI/WHO workshop report. NIH Publication, 2-9, 2002.
7. Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report. NIH Publication, 6-9, 2001.
8. Ishida T, Hashimoto T, Arita M, Ito M, Osawa M. Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest 114: 1588-1593, 1998.
9. Kobayashi N, Iikura M. Bacterial pneumonia in asthmatic patients. Arerugika 13: 329-335, 2002 (in Japanese).
10. To M, To Y, Yamada H, Ogawa C, et al. Clinical properties of community-acquire pneumonia in patients with asthma. Nihon Kokyuki Gakkai Zasshi (JJRS) 41: 89-94, 2003 (in Japanese, Abstract in English).
11. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 148: S1-S26, 1993.
12. Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 90: 32-42, 1992.
13. Lundgren R, Soderberg M, Horstedt, Stenling R. Morphological studies on bronchial mucosal biopsies from asthmatics before and after ten years treatment with inhaled steroids. Eur Respir J 1: 883-889, 1988.
14. Marston BJ, Plouffe JF, File TM Jr, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. Arch Intern Med 157: 1709-1718, 1997.